# Long COVID Research Moonshot Act

This bill directs the federal government to launch a major research initiative focused on understanding and treating Long COVID—the condition where people continue experiencing symptoms weeks or months after their initial COVID-19 infection. Think of it like the "moonshot" approach the government used for cancer research: dedicating significant resources and coordination across multiple agencies to tackle a specific health problem that affects millions of Americans.

The bill essentially tells the National Institutes of Health and other federal health agencies to prioritize Long COVID research and make it a coordinated effort rather than scattered projects. This means more funding, more researchers working on the problem, and a strategic plan to figure out what causes Long COVID, why some people get it and others don't, and how to treat it effectively. The government would need to set specific goals and timelines, track progress, and report back to Congress on what they're learning.

Who does this affect? Anyone suffering from Long COVID—which includes people who struggle with fatigue, brain fog, breathing problems, or other lingering symptoms after COVID infection. It could also benefit healthcare providers who need better tools to diagnose and treat these patients. Researchers in universities and medical centers would have access to more funding opportunities. Ultimately, if the research succeeds, it could lead to actual treatments that help millions of people return to normal functioning, which would reduce healthcare costs and help people get back to work and their daily lives.